National Research Corp Stock Cash And Equivalents
| NRC Stock | USD 19.66 0.18 0.92% |
National Research Corp fundamentals help investors to digest information that contributes to National Research's financial success or failures. It also enables traders to predict the movement of National Stock. The fundamental analysis module provides a way to measure National Research's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to National Research stock.
National | Cash And Equivalents |
National Research Corp Company Cash And Equivalents Analysis
National Research's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current National Research Cash And Equivalents | 32.97 M |
Most of National Research's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, National Research Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
National Cash And Equivalents Driver Correlations
Understanding the fundamental principles of building solid financial models for National Research is extremely important. It helps to project a fair market value of National Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since National Research's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of National Research's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of National Research's interrelated accounts and indicators.
Click cells to compare fundamentals
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
National Cash And Cash Equivalents Changes
Cash And Cash Equivalents Changes |
|
In accordance with the recently published financial statements, National Research Corp has 32.97 M in Cash And Equivalents. This is 95.98% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The cash and equivalents for all United States stocks is 98.78% higher than that of the company.
National Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses National Research's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of National Research could also be used in its relative valuation, which is a method of valuing National Research by comparing valuation metrics of similar companies.National Research is currently under evaluation in cash and equivalents category among its peers.
National Research ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, National Research's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to National Research's managers, analysts, and investors.Environmental | Governance | Social |
National Fundamentals
| Return On Equity | 0.59 | ||||
| Return On Asset | 0.19 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 511.71 M | ||||
| Shares Outstanding | 23.48 M | ||||
| Shares Owned By Insiders | 37.30 % | ||||
| Shares Owned By Institutions | 52.08 % | ||||
| Number Of Shares Shorted | 343.79 K | ||||
| Price To Earning | 26.72 X | ||||
| Price To Book | 13.33 X | ||||
| Price To Sales | 3.20 X | ||||
| Revenue | 148.58 M | ||||
| Gross Profit | 94.52 M | ||||
| EBITDA | 45.98 M | ||||
| Net Income | 30.97 M | ||||
| Cash And Equivalents | 32.97 M | ||||
| Cash Per Share | 1.33 X | ||||
| Total Debt | 38.96 M | ||||
| Debt To Equity | 0.37 % | ||||
| Current Ratio | 1.31 X | ||||
| Book Value Per Share | 1.48 X | ||||
| Cash Flow From Operations | 38.11 M | ||||
| Short Ratio | 4.37 X | ||||
| Earnings Per Share | 1.12 X | ||||
| Price To Earnings To Growth | 3.42 X | ||||
| Number Of Employees | 435 | ||||
| Beta | 0.53 | ||||
| Market Capitalization | 461.54 M | ||||
| Total Asset | 122.44 M | ||||
| Retained Earnings | (30.53 M) | ||||
| Working Capital | (11.84 M) | ||||
| Current Asset | 27.6 M | ||||
| Current Liabilities | 12.83 M | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.24 % | ||||
| Net Asset | 122.44 M | ||||
| Last Dividend Paid | 0.48 |
About National Research Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze National Research Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National Research using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National Research Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether National Research Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Research's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Research Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Research Corp Stock:Check out National Research Piotroski F Score and National Research Altman Z Score analysis. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.25) | Dividend Share 0.48 | Earnings Share 1.12 | Revenue Per Share 6.013 | Quarterly Revenue Growth (0.06) |
The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.